Eros International Plc (EROS) 16.13 $EROS Eros

New Post Public Reply Private Reply Replies (0) Message Board

Sep 22, 2016 at 1:00 PM

Eros International Plc (EROS) 16.13 $EROS

Eros International Plc Raises $30 Million From Two Existing Top 10 Shareholders
BusinessWire - Thu Sep 22, 8:14AM CDT
Eros International Plc (NYSE:EROS) ("Eros"

, a leading global company in the Indian film entertainment industry, today announced that two existing top ten institutional shareholders of the Company have increased their holdings in Eros. The Company raised approximately $30 million through a private placement, the proceeds of which will be primarily used to fund further expansion of Eros Now, the Company's OTT platform.
EROS: 16.13 (-0.12)

Lions Gate Partners With Vimeo to Enhance Online Services.
Zacks Equity Research - Zacks Investment Research - Wed Sep 14, 8:03AM CDT
Lions Gate (LGF) has inked a deal with online video-sharing platform Vimeo in order to deliver world-class online services to its customers.
LGF: 21.22 (+0.25), IAC: 62.48 (+0.90), EROS: 16.13 (-0.12), NWSA: 13.97 (+0.04)

Eros International Plc Reports Results for First Quarter FY 2017
BusinessWire - Fri Sep 09, 7:28AM CDT
Eros International Plc (NYSE: EROS) ("Eros" or "the Company"

, a leading global company in the Indian film entertainment industry, today reported its quarterly financial results for the three months ended June 30, 2016.
EROS: 16.13 (-0.12)

Eros Now Launches eBuzz Exclusively on Apple TV
BusinessWire - Tue Sep 06, 7:25AM CDT
Eros International Plc (NYSE: EROS) ("Eros"

, a leading global company in the Indian film entertainment industry, announced today that Eros Now, its global digital over-the-top distribution service, has recently added Eros Now's eBuzz video content exclusively to the Eros Now Apple TV service. eBuzz provides Apple TV viewers with the latest detail on Bollywood events and news.
EROS: 16.13 (-0.12)

Eros Now Announces Integration Deal with Reliance Jio
BusinessWire - Thu Aug 25, 9:59AM CDT
Eros International Plc (NYSE:EROS) ("Eros"

, a leading global company in the Indian film entertainment industry, announced today a landmark deal between Eros Now, its cutting edge digital over-the-top (OTT) platform, and Reliance Jio ("Jio"

, a provider of mobile telephony, broadband services, and digital services in India.
EROS: 16.13 (-0.12)

Eros International to Report First Quarter Fiscal Year 2017 Results on September 9, 2016
BusinessWire - Thu Aug 25, 8:57AM CDT
Eros International Plc (NYSE:EROS) ("Eros"

, a leading global company in the Indian film entertainment industry, announced today that it will issue a press release to report its results for first quarter fiscal year 2017 before the market opens on Friday, September 9, 2016. The Company will host a conference call that day at 8:30 AM ET.
EROS: 16.13 (-0.12)

Media Stocks to Watch for Earnings Next Week: MSGN, EROS
Zacks Equity Research - Zacks Investment Research - Fri Aug 12, 6:17AM CDT
We expect earnings for the quarter to be down 3.4% from the same period last year on 0.4% lower revenues.
MSGN: 18.35 (+0.15), EROS: 16.13 (-0.12)

Covered Call reports for Gilead Sciences, Intrexon, Ralph Lauren, Smith & Wesson and Eros International include trade ideas that offer returns of 20% or more!
PR Newswire - Thu Aug 11, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for EROS, GILD, RL, SWHC, and XON.
GILD: 81.30 (-0.40), XON: 28.11 (unch), RL: 98.95 (-0.16), EROS: 16.13 (-0.12), SWHC: 27.39 (-0.41)

Lions Gate Entertainment (LGF): What's Up in Q1 Earnings?
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 9:33AM CDT
Lions Gate Entertainment Corp. (LGF), a producer and distributor of motion pictures for theatrical and straight-to-video releases, is expected to report first-quarter fiscal 2017 results on Aug 4, 2016, after the closing bell.
TIVO: 21.27 (-0.15), LGF: 21.22 (+0.25), EROS: 16.13 (-0.12), TWX: 77.53 (+0.87)

News Corp. (NWSA) Q4 Earnings: Will the Stock Disappoint?
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 6:10AM CDT
Our proven model does not conclusively show that News Corporation (NWSA) is likely to beat earnings estimates this quarter.
TIVO: 21.27 (-0.15), EROS: 16.13 (-0.12), NWSA: 13.97 (+0.04), TWX: 77.53 (+0.87)

Time Inc. (TIME): What Will Q2 Earnings Release Unveil?
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 6:07AM CDT
Our proven model does not conclusively show that Time Inc. (TIME) is likely to beat estimates this quarter.
TIME: 14.68 (+0.05), TIVO: 21.27 (-0.15), EROS: 16.13 (-0.12), TWX: 77.53 (+0.87)

Will 21st Century Fox (FOXA) Q4 Earnings Be a Letdown?
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 5:30PM CDT
Twenty-First Century Fox, Inc. (FOXA) is scheduled to report fourth-quarter fiscal 2016 results on Aug 3, after the closing bell.
TIVO: 21.27 (-0.15), FOXA: 24.34 (+0.34), EROS: 16.13 (-0.12), TWX: 77.53 (+0.87)

MGM Resorts (MGM) Q2 Earnings: Will Macau Hurt Results?
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 10:28AM CDT
MGM Resorts International (MGM) is set to report second-quarter 2016 results on Aug 4, before the opening bell. Last quarter, the company posted a positive earnings surprise of 23.08%.
RLH: 8.04 (+0.28), MGM: 25.69 (+0.61), EROS: 16.13 (-0.12), TWX: 77.53 (+0.87)

Will Soft Sales Keep Hurting SeaWorld (SEAS) Q2 Earnings?
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 9:16AM CDT
SeaWorld Entertainment, Inc. (SEAS) is set to report second-quarter 2016 results on Aug 4, before the market opens.
RLH: 8.04 (+0.28), SEAS: 13.28 (+1.00), EROS: 16.13 (-0.12), TWX: 77.53 (+0.87)

Time Warner (TWX): Stock Poised to Beat Earnings in Q2?
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 6:47AM CDT
Our proven model shows that Time Warner (TWX) is likely to beat earnings estimates this quarter.
TIVO: 21.27 (-0.15), M: 36.21 (+0.20), EROS: 16.13 (-0.12), TWX: 77.53 (+0.87)

Eros Now and Micromax Form Strategic Partnership to Offer Endless Entertainment
BusinessWire - Fri Jun 24, 7:43AM CDT
Eros International Plc (NYSE: EROS) ("Eros"

, a leading company in the Indian film entertainment industry, today announced a strategic partnership between its cutting edge OTT digital platform, Eros Now and Micromax Informatics Limited, one of the world's leading handset manufactures, to bring endless entertainment to Micromax consumers.
EROS: 16.13 (-0.12)

Eros International Signs Television License Deal with Zee Network
BusinessWire - Fri Jun 17, 8:48AM CDT
Eros International Plc (NYSE:EROS) ("Eros"

, a leading global company in the Indian film entertainment industry, announced today a television syndication deal for their new and catalogue films with Zee Network, one of India's leading television media and entertainment companies. The films comprise a number of catalogue films from Eros' vast library and also pre-sales for a few forthcoming films.
EROS: 16.13 (-0.12)

Eros Now Available on Android TV
BusinessWire - Thu Jun 16, 12:39PM CDT
Eros International Plc (NYSE:EROS) ("Eros"

, a leading global company in the Indian film entertainment industry, announced today that Eros Now, its digital over-the-top distribution service, is now available on Android TV.
EROS: 16.13 (-0.12)

Eros Now supports 'Watch Offline' Feature on Android & iOS Devices
BusinessWire - Wed Jun 15, 8:17AM CDT
Eros International Plc (NYSE:EROS) ("Eros"

, a leading global company in the Indian film entertainment industry, announced today the introduction of 'Watch Offline' services across all iOS platforms for it premium customers at no additional charge on Eros Now, its digital over-the-top distribution service for Indian language entertainment. The company had recently announced the offline viewing service on Android devices.
EROS: 16.13 (-0.12)

Eros International Plc Remains Confident in its Financial Accounting Practices and Integrity of its Business and Operations
BusinessWire - Thu Jun 09, 12:55PM CDT
Eros International Plc (NYSE:EROS) ("Eros"

, a leading global company in the Indian film entertainment industry, today made the following statement:
EROS: 16.13 (-0.12)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Deadline Looms for EquipmentShare Investors' Legal Action

Pressure Builds for EquipmentShare Investors If you've thrown some cash into EquipmentShare.com Inc. (NASDAQ: EQPT), it's time to sit up and pay attention. There's smoke on the horizon, and Faruqi & Faruqi, LLP is waving the flag. They've got a securities class action spinning fast, and if you've suffered any losses, September 21, 2026, is a date you don't want to forget....

XKL Delivers MediaLight for High-Speed Optical Transport

Unpacking the MediaLight Launch Kicking off September, XKL is tossing its hat in the ring with the MediaLight Xponder and Muxponder systems. These aren't just any run-of-the-mill gizmos—nope, they're touted as top-of-the-line optical transport solutions. The talk of the town is their ability to dish out high-density 100G and 400G transport, and for geeks in the trade,...

Rare Collectibles Highlight Morphy's Auction on Oct 4

Anticipation Builds for Morphy's Auction Event Morphy's upcoming event on October 4th is all about tapping into the era of revved engines, gleaming gasoline signs, and some history that could put Hollywood tales to shame. The auction isn't just a stroll down memory lane; it features over 650 lots, each a time capsule of America's automotive past. From Al Capone's ritzy...

Veteran Marketer Joins The Wisory's Advisory Board

Tyrrell Schmidt Joins The Wisory's Board Out of the blue, The Wisory has snatched Tyrrell Schmidt right off the retirement bench. This doesn't seem like just another board seating; it smells like a calculated power play. Schmidt, fresh from her heavyweight stint as Global CMO at TD Bank, adds a spicy dose of marketing prowess to The Wisory's already loaded Advisory Board....

K-9 Hero Act Aims to Ease Costs for Retired Dogs' Care

Let's Talk About the Loyalty that Dogs Deserve Who would've thought we'd be chatting about our four-legged heroes in a federal setting? But here we are, giving well-deserved attention to those furry federal agents. They're the ones who sniff out bombs and tackle crooks, and they're not asking for a retirement plan with a yacht – just some vet care! What the K-9 Hero Act...

GBI Bio's New CEO Jesse McCool to Propel Growth

Jesse McCool stepping into GBI's CEO shoes is the kind of move that makes you sit up straight and take notice. Let me tell you, the biomanufacturing scene is buzzing with this appointment, and McCool's got his work cut out for him in leading GBI Biomanufacturing's shift towards commercial-scale operations while expanding their early-stage biotech portfolio. A Veteran in...

OneAscent Welcomes Monica Stoudemire as New CCO

New Leadership in Compliance Diving straight into the tumultuous sea of securities compliance, OneAscent's got a fresh captain at the helm. Monica Stoudemire's stepped into the Chief Compliance Officer's shoes with a track record that'd make any investor breathe a sigh of relief. After all, blending two decades of on-the-ground experience with regulatory acumen ain't...

Albertsons Welcomes Once Upon a Coconut Nationwide

Coconut Water Takes Over Grocery Aisles You know, for all the cautious optimism I wield, this here is a move that shows real muscle in the world of coconut water—I mean, slamming into Albertsons' grocery empire is no small potatoes! Once Upon a Coconut has landed its premium hydration cans across all the banners under this giant retailer. From that good ol' familiar...

Mobile Iron IV Expansions: Targeting Texas Health Needs

Out in Texas, folks facing iron deficiency have a new game-changer coming their way. Drip Gym, the same outfit making waves out in Queens and Long Island, is taking their mobile iron IV therapy clinic straight to Texan doorsteps. No more trotting off to a clinic for iron infusions with this crew rolling into Houston, Dallas, Austin, and San Antonio. What's the Big Deal?...

AbbVie's Bold Leap in Menstrual Migraine Treatment

AbbVie's Game-Changing Atogepant Study When it comes to pushing boundaries in the pharmaceutical world, there's no sitting on the fence. AbbVie's Phase 3 LUNA study results are painting a bright picture for women who suffer from the relentless grip of menstrual migraines. In a world where not a single treatment option has been approved specifically for this condition,...